Introduction {#Sec1}
============

The Third International Consensus Definitions for Sepsis and Septic Shock proposes the use of a simplified SOFA (Sequential Organ Failure Assessment) score, termed quickSOFA (qSOFA), for patients with suspected infection outside intensive care to rapidly identify those at high risk for dying \[[@CR1], [@CR2]\]. The qSOFA score includes respiratory rate, altered mental status, and systolic blood pressure which are readily available in any setting. As such, the qSOFA score could be of particular relevance in resource-limited regions. We previously did a retrospective analysis of the qSOFA score in adult patients admitted to hospital in Lambaréné, Gabon, with suspected infection (including bacterial infection and/or malaria). In this setting, a qSOFA score ≥2 had a sensitivity of 87% (95% CI 60--98%) and specificity of 75% (95% CI 70--80%), with an area under the receiver-operating characteristic (AUROC) of 0.83 (95% CI 0.74--0.93) in patients with suspected infection \[[@CR3]\]. We report here on the first prospective qSOFA score study in a resource-limited setting. We examined the performance of qSOFA to predict mortality in patients with suspected infection in Kamuzu Central Hospital (KCH), a 750-bed tertiary care hospital in Lilongwe, Malawi, with a catchment population of over 5 million people. A previous study in this hospital demonstrated that altered mental state, which is also included in qSOFA, was associated with high mortality rates \[[@CR4]\], but the qSOFA score has not been previously evaluated in KCH.

Methods {#Sec2}
=======

Data collection {#Sec3}
---------------

During 6 weeks in November and December 2016, all consecutive patients admitted to the adult medical ward of KCH were included. The qSOFA score was calculated for all with suspected infection, defined by the start of antibiotics, antimalarials or antituberculous medication. The qSOFA score allocates one point for each of the following: respiratory rate ≥22/min, altered mentation \[Glasgow Coma Scale (GCS) of ≤14\], or systolic blood pressure ≤100 mmHg. Data collection was based on routine clinical observations, supplemented by a dedicated physician who checked all new admissions twice daily and recorded vital signs included in the qSOFA score in case of missing data. Therefore, every patient had a qSOFA score recorded within 12 h of admission. HIV status and final diagnoses were recorded, based on routine clinical observations, as well as in-hospital mortality (the primary study endpoint), and duration of hospital stay. Patients who were transferred out or who absconded were excluded from the analysis. All data were entered into an anonymized excel database. Informed consent need was waived by the ethical board of KCH.

Statistical analyses {#Sec4}
--------------------

Continuous variables are presented as median with interquartile range \[IQR\]. Categorical variables are expressed as number and percentage. Comparisons were made using a Mann--Whitney *U* test for continuous variables and Fisher's exact *t* test for categorical variables. Patients with missing values for the qSOFA score were excluded from the primary analyses. To assess the performances of the qSOFA to predict in-hospital mortality, we calculated sensitivity, specificity, and negative and positive predictive values for a qSOFA score of ≥2. We also calculated the area under the receiver-operating characteristic curve (AUROC). All statistical analyses were 2-tailed, and a *P* value \<0.05 was considered significant. GraphPad Prism was used for statistical analyses (GraphPad Software, La Jolla, California).

Results {#Sec5}
=======

During the study period 650 patients were admitted, of which 518 (80%) had a suspected infection. Information on follow-up or qSOFA score was incomplete in 60 patients, leaving 458 patients for analysis. Baseline characteristics are given in Table [1](#Tab1){ref-type="table"}. In-hospital mortality was 23% and 41% of patients had a qSOFA score ≥2, reflecting the very sick population that KCH receives as a tertiary referral center. Mortality was 3% in patients with a qSOFA score of 0, and 13%, 35% and 63% in patients with a qSOFA score of 1, 2, and 3, respectively. A HIV test result was available for 87% of patients, of whom 54% was positive. The most common diagnosis was suspected bacterial infection. The qSOFA score outperformed GCS as a single parameter to predict mortality, with an AUROC of 0.73 (95% CI 0.68--0.78) compared to 0.70 (95% CI 0.63--0.76; Table [2](#Tab2){ref-type="table"}). However, sensitivity was increased from 72% (95% CI 62--80) to 79% (95% CI 70--87) by allocating more weight to the GCS in the qSOFA score, thus classifying both patients with qSOFA ≥ 2 or GCS \< 15 as a high-risk group, while specificity decreased only moderately from 68% (95% CI 63--73) to 63% (95% CI 58--68), resulting in an AUROC of 0.77 (95% CI 0.72--0.82).Table 1Baseline characteristics of study participantsCharacteristicsAll patients *n* = 458In-hospital death *n* = 106Discharged *n* = 352*P* valueDemographics Male, *n* (%)243 (53.1)63 (59.4)180 (51.1)0.15 Age (years), median \[IQR\]35 \[26--47\]40 \[30--52\]33.5 \[25--45\]0.001HIV status HIV status known, *n* (%)397 (86.7)92 (86.8)305 (86.6)1.0 HIV positive, *n* (%)^a^213 (53.7)50 (54.3)163 (53.4)0.91 On cART, *n* (%)^b^166 (77.9)39 (78)127 (77.9)1.0 New HIV diagnosis, *n* (%)^b^20 (9.4)4 (8)16 (9.8)1.0qSOFA parameters BP systolic (mmHg), median \[IQR\]110 \[97--122\]110 \[91.5--129\]111 \[98--121\]0.37 Respiratory rate (breaths/min), median \[IQR\]28 \[20--32\]28 \[24--37.75\]27 \[20--32\]0.002 Altered mental status, *n* (%)117 (25.5)59 (55.7)58 (16.5)\<0.0001 qSOFA 0, *n* (%)69 (15.1)2 (1.9)67 (19)\<0.0001 qSOFA 1, *n* (%)201 (43.9)28 (26.4)173 (49.1)\<0.0001 qSOFA 2, *n* (%)169 (36.9)64 (60.4)105 (29.8)\<0.0001 qSOFA 3, *n* (%)19 (4.1)12 (11.3)7 (2)0.0002 qSOFA ≥ 2, *n* (%)188 (41)76 (71.7)112 (31.8)\<0.0001Diagnoses Suspected bacterial infection^c^225 (49.1)63 (59.4)162 (46)0.012 Probable bacterial infection^d^37 (8.1)5 (4.7)32 (9.1)0.22 PTB30 (6.6)6 (5.7)24 (6.8)0.82 EPTB40 (8.7)12 (11.3)28 (8)0.33 Cryptococcal meningitis9 (2)1 (0.9)8 (2.3)0.31 Malaria35 (7.6)3 (2.8)32 (9.1)0.04 Gastro-enteritis38 (8.3)3 (2.8)35 (9.9)0.02 cART failure12 (2.6)1 (0.9)11 (3.1)0.31 Other14 (3.1)5 (4.7)9 (2.6)0.33Secondary outcome Length of stay (days), median \[IQR\]4 \[2--7\]2.5 \[1--5\]5 \[2--7\]\<0.0001*IQR* inter quartile range, *cART* combination antiretroviral therapy, *qSOFA* quick sequential organ failure assessment, *BP* blood pressure, *PTB* pulmonary tuberculosis, *EPTB* extrapulmonary tuberculosis^a^ Percentage of patients with a known HIV status^b^ Percentage of HIV positive patients^c^ Defined by the initiation of antibiotic therapy^d^ Diagnosis supported by imaging or culture results Table 2Predictive value of qSOFAqSOFA ≥ 2GCS \< 15qSOFA ≥ 2 and/or GCS \< 15qSOFA + HIV status ≥ 2Sensitivity, % (95% CI)72 (62--80)56 (46--65)79 (70--87)87 (78--93)Specificity, % (95% CI)68 (63--73)84 (79--87)63 (58--68)44 (38--50)Positive predictive value, % (95% CI)40 (33--47)50 (41--60)39 (33--46)32 (26--38)Negative predictive value, % (95% CI)89 (84--92)86 (82--90)91 (86--94)92 (86--95)AUROC (95% CI)0.73 (0.68--0.78)0.70 (0.63--0.76)0.77 (0.72--0.82)0.68 (0.62--0.74)*qSOFA* quick sequential organ failure assessment, *GCS* Glasgow coma scale, *AUROC* area under the receiver-operating characteristic

A large patient proportion was HIV positive; so we also assessed the impact of adding HIV status as an additional risk factor to the qSOFA score. By allotting one extra point for HIV seropositivity but still applying a ≥2 cut-off to the total score, sensitivity increased to 87% (78--93) (Table [2](#Tab2){ref-type="table"}). However, specificity decreased to 44% (38--50) and the AUROC fell to 0.68 (0.62--0.74). We also analyzed the performance of the qSOFA score separately in HIV positive and HIV negative patients (Supplementary Table 1 and 2) and found predictive value to be equal in both groups.

Discussion {#Sec6}
==========

We found a reasonably good ability of the qSOFA score to predict mortality with an AUROC of 0.73 (95% CI 0.68--0.78), which could be increased to 0.77 (95% CI 0.72--0.82) when patients with altered mental status were classified as high risk regardless of other qSOFA criteria.

The qSOFA score performance was less in the study reported here compared to our retrospective study in Gabon, where we found an AUROC of 0.83 (95% CI 0.74--0.93). Possibly, the differences are related to severity of illness on presentation, or standards of care. As such, there may not be a one-size-fits-all risk score. qSOFA may serve as a simple tool for risk stratification, but requires further prospective validation in different settings. For example, others have compared qSOFA to the CURB-65 for pneumonia patients and found improved predictive ability of the qSOFA score when age of ≥65 or greater was added as risk factor \[[@CR5]\]. The value of such an addition depends highly on the patient population, as the median age of our patients was 35 years, with only 11% of patients aged above 64. We also examined the added value of HIV status in risk stratification; however, in the Malawian setting, this resulted in a very low specificity, leading to misclassification of low-risk patients. Prioritizing limited resources to such a large group of patients is unsustainable, so we do not recommend incorporating HIV status in risk stratification in our setting.

Limitations of our study include the single-center design and lack of a definite diagnosis in most patients. However, this reflects the clinical reality in many resource-limited settings and a risk stratification score should be useful regardless of the final diagnosis at discharge.

In conclusion, we report the first prospective data on the ability of qSOFA to predict mortality in a resource-limited setting and found that the qSOFA score is a simple tool that can aid risk stratification in this environment. However, the predictive performance of qSOFA may vary between patient populations. Our observations were made in a very sick population in a tertiary referral centre, and we emphasize the need to further validate qSOFA in different settings, for example, in primary care in resource-limited areas, where qSOFA might help select patients for referral.
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